Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents
July 19, 2017

Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis

Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents

Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents


The Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis which was published in the International journal of antimicrobial agents. Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasis - International Journal of Antimicrobial Agents Human African trypanosomiasis (HAT) is a neglected tropical disease, with a population of 70 million at risk. Current treatment options are limited.


In the search for new therapeutics, the repurposing of the broad-spectrum antiprotozoal drug fexinidazole has completed Phase III trials with the anticipation that it will be the first oral treatment for HAT.


For more information please see - https://www.sciencedirect.com/journal/international-journal-of-antimicrobial-agents

SMR Women’s Health Meeting
June 17, 2025
We’re excited to share that Janette Robertson (Business Development Manager) and Professor Mo Alavijeh (Managing Director) will attend the SMR Women’s Health Meeting at Friends House, London. They look forward to meeting attendees and discussing collaboration opportunities in drug discovery and development, especially in women’s health. 📅 More info: https://www.smr.org.uk/Meetings/20250617/ 🤝 Let’s connect in London!
June 16, 2025
👉 www.pharmidex.com/medical-device-testing-services With over 23 years of experience in preclinical R&D, we’re expanding our capabilities to support the development and regulatory testing of innovative medical devices from biocompatibility assessments to in vitro and in vivo efficacy models. This new service allows us to collaborate even more closely with biotech companies, CRO partners, academic innovators and medical device startups helping bring safe, effective and transformative technologies to patients faster. Whether you're exploring a novel implant, delivery system, or diagnostic platform, our team is ready to support you at every step with the same scientific integrity and agility that Pharmidex is known for. 💡 Let’s accelerate innovation, together.
June 11, 2025
Pharmidex team are delighted to participate in workshop on "Re-shaping UK life science commercialisation strategy" organised by The Research and Development Society on Wednesday 11th June, at Mereside, Alderley Park. If you are attending, please linkup with our colleague Mo Alavijeh who will be delighted to meet you. Jamie Phadke , Alderley Park #UKlifescience https://lnkd.in/e6uKsRcN
More Posts